Aligos Therapeutics, Inc. (NASDAQ:ALGS) Financings
Financings
| Raise | Date |
|---|---|
| Private placement of common stock, pre-funded warrants and accompanying warrants Announced: about US$105M · US$26.0825 a share · Warrants at US$26.02 · Jefferies +2 Dealers: Jefferies, Piper Sandler, H.C. Wainwright & Co. Use of proceeds: Advance ALG-000184 into a Phase 2 study in chronic hepatitis B and general corporate purposes | Feb 12, 2025 |